Friday 6 November 2026
Export VTRS’s income statement to Excel — free account
Viatris Inc.
VTRS Healthcare Drug Manufacturers Specialty & Generic
Viatris Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, down 2.98% from fiscal 2024.
- Revenue
- −0.28%
- EPS
- −154.6%
- Free cash flow
- +38.8%
- Total debt
- −89.4%
Quarter to September 2026, against a year earlier
19.08
0.11
+0.58%
Follow VTRS
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 5 Nov | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(21.08%) | (1.96%) | (2.75%) | (4.21%) | |
Piotroski F-Score |
5 | 6 | 7 | — | |
| (8.93%) | (0.79%) | (1.12%) | (1.67%) | ||
ROIC |
(5.99%) | 0.32% | (0.20%) | (0.02%) | |
Return on Tangible Assets |
(66.21%) | (4.47%) | (6.68%) | (9.99%) | |
Average Days of Receivables |
77.37 | 77.11 | 77.43 | 77.36 | |
Free Cash Flow per Share |
1.66 | 1.49 | 1.63 | 0.00 | |
Free Cash Flow |
1,939.00 | 1,721.60 | 1,890.60 | 2,396.80 | |
Capital Expenditures |
(376.90) | (447.10) | (440.20) | (88.50) | |
| Other line items | |||||
Cash ROIC |
6.37% | 5.59% | 6.63% | 13.93% | |
Accounts Receivable Turnover |
4.57 | 4.70 | 4.62 | 4.54 | |
Accounts Payable Turnover |
5.15 | 5.11 | 5.47 | 5.53 | |
Inventory Turnover |
2.37 | 2.38 | 2.34 | 2.40 | |
Average Days of Payables |
68.94 | 66.84 | 65.61 | 63.34 | |
Days of Inventory on Hand |
157.19 | 150.04 | 149.48 | 146.70 | |
Tax Rate |
(0.04) | (0.64) | (0.38) | 0.15 | |
Research and Development Expense of Revenue |
6.75% | 6.82% | 6.93% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
26.53% | 25.92% | 27.01% | 27.47% | |
Share Based Compensation of Revenue |
1.24% | 1.17% | 1.17% | 1.19% | |
Interest Coverage |
(5.65) | 0.29 | (0.18) | (0.01) | |
Operating CF/Net income |
(0.66) | (7.31) | (5.68) | (4.09) | |
Depreciation/Fixed assets |
2.19 | 1.11 | 1.15 | 0.00 | |
Capex/Depreciation |
(0.07) | (0.16) | (0.16) | 0.00 | |
Revenue per Share |
12.21 | 12.60 | 12.67 | 0.00 | |
Operating CF per Share |
1.98 | 1.88 | 2.00 | 0.00 | |
Capex per Share |
(0.32) | (0.39) | (0.38) | 0.00 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026